Synovics Pharmaceuticals, Inc.
SYVC
$0.00
$0.000.00%
OTC PK
| 07/31/2009 | 04/30/2009 | 01/31/2009 | 10/31/2008 | 07/31/2008 | |
|---|---|---|---|---|---|
| Net Income | -2.02M | -2.59M | -1.10M | 670.30K | 489.70K |
| Total Depreciation and Amortization | 215.40K | 130.90K | 155.40K | 172.50K | 153.90K |
| Total Amortization of Deferred Charges | 36.70K | 301.40K | 340.80K | 596.60K | 2.85M |
| Total Other Non-Cash Items | 130.00K | 109.50K | 369.30K | 878.50K | 1.10M |
| Change in Net Operating Assets | 1.70M | 2.14M | 828.60K | -1.07M | -2.16M |
| Cash from Operations | 60.70K | 88.10K | 593.00K | 1.25M | 2.44M |
| Capital Expenditure | -43.10K | 1.80K | -49.40K | -122.20K | -323.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -43.10K | 1.80K | -49.40K | -122.20K | -323.10K |
| Total Debt Issued | 1.25M | -- | -- | 0.00 | -119.50K |
| Total Debt Repaid | -1.15M | -100.20K | -590.00K | -2.28M | -7.51M |
| Issuance of Common Stock | -- | -- | -- | 796.70K | 5.92M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 103.00K | -100.20K | -590.00K | -1.48M | -1.71M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 0.00 | -- |
| Net Change in Cash | 120.60K | -10.30K | -46.40K | -360.10K | 404.20K |